Prasad Wealth Partners LLC increased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 27.3% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 2,140 shares of the social networking company’s stock after acquiring an additional 459 shares during the quarter. Prasad Wealth Partners LLC’s holdings in Meta Platforms were worth $1,580,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Foundation Wealth Management LLC raised its stake in Meta Platforms by 6.3% in the 2nd quarter. Foundation Wealth Management LLC now owns 374 shares of the social networking company’s stock worth $276,000 after purchasing an additional 22 shares in the last quarter. Roundview Capital LLC raised its stake in Meta Platforms by 9.7% in the 2nd quarter. Roundview Capital LLC now owns 35,209 shares of the social networking company’s stock worth $25,987,000 after purchasing an additional 3,099 shares in the last quarter. Sachetta LLC raised its stake in Meta Platforms by 4.8% in the 2nd quarter. Sachetta LLC now owns 943 shares of the social networking company’s stock worth $696,000 after purchasing an additional 43 shares in the last quarter. Sunbeam Capital Management LLC raised its stake in Meta Platforms by 3.2% in the 2nd quarter. Sunbeam Capital Management LLC now owns 3,220 shares of the social networking company’s stock worth $2,377,000 after purchasing an additional 101 shares in the last quarter. Finally, CFM Wealth Partners LLC raised its stake in Meta Platforms by 4.8% in the 2nd quarter. CFM Wealth Partners LLC now owns 26,674 shares of the social networking company’s stock worth $19,688,000 after purchasing an additional 1,226 shares in the last quarter. Institutional investors own 79.91% of the company’s stock.
Meta Platforms Trading Up 1.3%
META opened at $717.55 on Thursday. Meta Platforms, Inc. has a fifty-two week low of $479.80 and a fifty-two week high of $796.25. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.97 and a quick ratio of 1.97. The firm has a market capitalization of $1.80 trillion, a price-to-earnings ratio of 25.98, a PEG ratio of 1.48 and a beta of 1.20. The company’s 50 day moving average price is $748.80 and its two-hundred day moving average price is $681.19.
Meta Platforms Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, September 29th. Shareholders of record on Monday, September 22nd were issued a dividend of $0.525 per share. This represents a $2.10 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Monday, September 22nd. Meta Platforms’s payout ratio is presently 7.60%.
Insider Activity
In other news, insider Jennifer Newstead sold 519 shares of the company’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $716.98, for a total value of $372,112.62. Following the sale, the insider directly owned 29,313 shares of the company’s stock, valued at approximately $21,016,834.74. This represents a 1.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert M. Kimmitt sold 465 shares of the company’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $757.47, for a total transaction of $352,223.55. Following the completion of the sale, the director directly owned 8,412 shares in the company, valued at approximately $6,371,837.64. This represents a 5.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 213,198 shares of company stock valued at $164,232,558. 13.61% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Several analysts have weighed in on META shares. Truist Financial set a $880.00 price objective on shares of Meta Platforms in a research note on Thursday, September 18th. Canaccord Genuity Group lifted their price objective on shares of Meta Platforms from $825.00 to $850.00 and gave the stock a “buy” rating in a research note on Wednesday, July 16th. Morgan Stanley lifted their price objective on shares of Meta Platforms from $750.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 31st. TD Cowen boosted their target price on shares of Meta Platforms from $800.00 to $875.00 and gave the company a “buy” rating in a research report on Thursday, July 31st. Finally, Zacks Research cut shares of Meta Platforms from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 19th. Four research analysts have rated the stock with a Strong Buy rating, thirty-nine have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $830.68.
View Our Latest Stock Report on Meta Platforms
Meta Platforms Profile
Meta Platforms, Inc engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately.
See Also
- Five stocks we like better than Meta Platforms
- What is a SEC Filing?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Health Care Stocks Explained: Why You Might Want to Invest
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Basic Materials Stocks Investing
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding META? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Meta Platforms, Inc. (NASDAQ:META – Free Report).
Receive News & Ratings for Meta Platforms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Meta Platforms and related companies with MarketBeat.com's FREE daily email newsletter.